Compare HTFL & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HTFL | FMC |
|---|---|---|
| Founded | 2007 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | N/A | 1994 |
| Metric | HTFL | FMC |
|---|---|---|
| Price | $29.63 | $13.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 13 |
| Target Price | ★ $38.20 | $18.50 |
| AVG Volume (30 Days) | 969.0K | ★ 2.4M |
| Earning Date | 05-14-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,727,800,000.00 |
| Revenue This Year | $27.66 | $7.89 |
| Revenue Next Year | $23.55 | $4.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.13 | $12.17 |
| 52 Week High | $41.22 | $44.77 |
| Indicator | HTFL | FMC |
|---|---|---|
| Relative Strength Index (RSI) | 52.73 | 35.26 |
| Support Level | $28.60 | $12.88 |
| Resistance Level | $32.81 | $14.55 |
| Average True Range (ATR) | 1.57 | 0.88 |
| MACD | -0.28 | -0.26 |
| Stochastic Oscillator | 28.07 | 0.00 |
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.